Altered pregnancy outcomes in mice following treatment with the hyperglycaemia mimetic, glucosamine, during the periconception period

Reproduction, Fertility and Development

Volumn 25, Issue 2, 2013, Pages 405-416

  Schelbach, Cheryl J ^a   Robker, Rebecca L ^a   Bennett, Brenton D ^a   Gauld, Ashley D ^a   Thompson, Jeremy G ^a   Kind, Karen L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

fetal development; hexosamine biosynthesis pathway.

Indexed keywords

GLUCOSAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONGENITAL DISORDER; CONTROLLED STUDY; FEMALE; FETUS; FETUS OUTCOME; FETUS WEIGHT; GESTATIONAL AGE; GLUCOSE TOLERANCE; IN VIVO STUDY; LIPID DIET; LITTER SIZE; MALE; MATERNAL AGE; MATING; MOUSE; NONHUMAN; OBESITY; OOCYTE; OUTCOME ASSESSMENT; PERINATAL DRUG EXPOSURE; PREGNANCY OUTCOME; PREGNANCY RATE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; BODY SIZE; DIET, HIGH-FAT; EMBRYONIC DEVELOPMENT; FEMALE; GESTATIONAL AGE; GLUCOSAMINE; GLUCOSE TOLERANCE TEST; IN VITRO OOCYTE MATURATION TECHNIQUES; INSULIN; LITTER SIZE; MATERNAL AGE; MICE; MICE, INBRED C57BL; OVERWEIGHT; PREGNANCY; PREGNANCY OUTCOME;

EID: 84873858573     PISSN: 10313613     EISSN: 14485990     Source Type: Journal    
DOI: 10.1071/RD11313     Document Type: Article

References (84)

1. Adebowale, A., Du, J., Liang, Z., Leslie, J. L., and Eddington, N. D. (2002). The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm. Drug Dispos. 23, 217-225. doi:10.1002/BDD.315
2. Aghazadeh-Habashi, A., Sattari, S., Pasutto, F., and Jamali, F. (2002). Single dose pharmacokinetics and bioavailability of glucosamine in the rat. J. Pharm. Pharm. Sci. 5, 181-184.
3. Ali, S., and Dornhorst, A. (2011). Diabetes in pregnancy: health risks and management. Postgrad. Med. J. 87, 417-427. doi:10.1136/PGMJ.2010. 109157
4. Anderson, J. W., Nicolosi, R. J., and Borzelleca, J. F. (2005). Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem. Toxicol. 43, 187-201. doi:10.1016/J.FCT.2004.11.006
5. Barrientos, C., Racotta, R., and Quevedo, L. (2010). Glucosamine attenuates increasesof intraabdominal fat, serum leptin levels and insulin resistance induced by a high-fat diet in rats. Nutr. Res. 30, 791-800. doi:10.1016/J.NUTRES.2010.10.008
6. Buse, M. G. (2006). Hexosamines, insulin resistance and the complications of diabetes: current status. Am. J. Physiol. Endocrinol. Metab. 290, E1-E8. doi:10.1152/AJPENDO.00329.2005
7. Buse, M. G., Robinson, K. A., Gettys, T. W., McMahon, E. G., and Gulve, E. A. (1997). Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 272, E1080-E1088.
8. Butkinaree, C., Park, K., and Hart, G. W. (2010). O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphoryla-tion to regulate signalling and transcription in response to nutrients and stress. Biochim. Biophys. Acta 1800, 96-106. doi:10.1016/J.BBAGEN. 2009.07.018
9. Cardozo, E., Pavone, M. E., and Hirshfeld-Cytron, J. E. (2011). Metabolic syndrome and oocyte quality. Trends Endocrinol. Metab. 22, 103-109. doi:10.1016/J.TEM.2010.12.002
10. Chan, A., Scott, J., Nguyen, A.-M., and Sage, L. (2009). 'Pregnancy outcome in South Australia 2008'. (Adelaide Pregnancy Outcome Unit, SA Health, Government of South Australia: Adelaide.)
11. Colagiuri, S., Borch-Johnsen, K., Glumer, C., and Vistisen, D. (2005). There really is an epidemic of Type 2 diabetes. Diabetologia 48, 1459-1463. doi:10.1007/S00125-005-1843-Y
12. Combs, C. A., and Kitzmiller, J. L. (1991). Spontaneous abortion and congenital malformations in diabetes. Baillieres Clin. Obstet. Gynaecol. 5, 315-331. doi:10.1016/S0950-3552(05)80100-2
13. Considine, R. V., Cooksey, R. C., Williams, L. B., Fawcett, R. L., Zhang, P., Ambrosius, W. T., Whitfield, R. M., Jones, R., Inman, M., Huse, J., and McClain, D. A. (2000). Hexosamines regulate leptin production in human subcutaneous adipocytes. J. Clin. Endocrinol. Metab. 85, 3551-3556. doi:10.1210/JC.85.10.3551
14. Cooksey, R. C., and McClain, D. A. (2011). Increased hexosamine pathway flux and high-fat feeding are not additive in inducing insulin resistance: evidence for a shared pathway. Amino Acids 40, 841-846. doi:10.1007/S00726-010- 0701-5
15. Delbaere, I., Verstraelen, H., Goetgeluk, S., Martens, G., De Backer, G., and Temmerman, M. (2007). Pregnancy outcome in primiparae of advanced maternal age. Eur. J. Obstet. Gynecol. Reprod. Biol. 135, 41-46. doi:10.1016/J.EJOGRB. 2006.10.030
16. Diamond, M. P., Moley, K. H., Pellicer, A., Vaughn, W. K., and DeCherney, A. H. (1989). Effects of streptozotocin-and alloxan-induced diabetes mellitus on mouse follicular and early embryo development. J. Reprod. Fertil. 86, 1-10. doi:10.1530/JRF.0.0860001
17. Dostrovsky, N. R., Towheed, T. E., Hudson, R. W., and Anastassiades, T. P. (2011). The effect of glucosamine on glucose metabolism in humans: a systematic review of the literature. Osteoarthritis Cartilage 19, 375-380. doi:10.1016/J.JOCA.2011.01.007
18. Dunstan, D. W., Zimmet, P.Z., Welborn, T. A., DeCourten, M.P., Cameron, A. J., Sicree, R. A., Dwyer, T., Colagiuri, S., Jolley, D., Knuiman, M., Atkins, R., and Shaw, J. E. (2002). The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25, 829-834. doi:10.2337/DIACARE. 25.5.829
19. Einstein, F. H., Fishman, S., Bauman, J., Thompson, R. F., Huffman, D. M., Atzmon, G., Barzilai, N., and Muzumdar, R. H. (2008). Enhanced activation of a nutrient-sensing pathway with age contributes to insulin resistance. FASEB J. 22, 3450-3457. doi:10.1096/FJ.08-109041
20. Ericsson, A., Säljö, K., Sjöstrand, E., Jansson, N., Prasad, P. D., Powell, T. L., and Jansson, T. (2007). Brief hyperglycaemia in the early pregnant rat increases fetal weight at term by stimulating placental growth and affecting placental nutrient transport. J. Physiol. 581, 1323-1332. doi:10.1113/JPHYSIOL.2007.131185
21. Fleming, T. P., Lucas, E. S., Watkins, A. J., and Eckert, J. J.(2012). Adaptive responses of the embryo to maternal diet and consequences for post-implantation development. Reprod. Fertil. Dev. 24, 35-44. doi:10.1071/RD11905
22. Fowler, R. E. (1988). An autoradiographic study of gonadotrophin regulation of labelled glycoconjugates within preovulatory mouse follicles during the final stages of oocyte maturation, using [3H] glucosamine as the radioactive precursor. J. Reprod. Fertil. 83, 759-772. doi:10.1530/JRF.0.0830759
23. Fowler, R. E., and Barratt, E. (1989). The uptake of [3H] glucosamine-labelled glycoconjugates into the perivitelline space of preimplantation mouse embryos. Hum. Reprod. 4, 821-825.
24. Fowler, R. E., and Guttridge, K. (1987). An autoradiographic study using [3H] glucosamine of gonadotrophin regulation of proteoglycan and glycoprotein synthesis in developing mouse follicles. J. Reprod. Fertil. 81, 415-426. doi:10.1530/JRF.0.0810415
25. Friede, A., Baldwin, W., Rhodes, P. H., Buehler, J. W., and Strauss, L. T. (1988). Older maternal age and infant mortality in the United States. Obstet. Gynecol. 72, 152-157.
26. Fulop, N., Mason, M. M., Dutta, K., Wang, P., Davidoff, A. J., Marchase, R. B., and Chatham, J.C. (2007). Impact of Type 2diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. Am. J. Physiol. Cell Physiol. 292, C1370-C1378. doi:10.1152/AJPCELL.00422.2006
27. Greene, M. F. (1999). Spontaneous abortions and major malformations in women with diabetes mellitus. Semin. Reprod. Endocrinol. 17, 127-136. doi:10.1055/S-2007-1016220
28. Hansen, J. P. (1986). Older maternal age and pregnancy outcome: a review of the literature. Obstet. Gynecol. Surv. 41, 726-742. doi:10.1097/00006254- 198611000-00024
29. Heilig, C. W., Saunders, T., Brosius, F. C., Moley, K., Heilig, K., Baggs, R., Guo, L., and Conner, D. (2003). Glucose transporter-1-deficient mice exhibit impaired development and deformities similar to diabetic embryopathy. Proc. Natl. Acad. Sci. USA 100, 15 613-15 618. doi:10.1073/PNAS.2536196100
30. Horal, M., Zhang, Z., Stanton, R., Virkamaki, A., and Loeken, M. R. (2004). Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: involvement in diabetic teratogene-sis. Birth Defects Res. A Clin. Mol. Teratol. 70, 519-527. doi:10.1002/BDRA.20056
31. Hsieh, T. T., Liou, J. D., Hsu, J. J., Lo, L. M., Chen, S. F., and Hung, T. T. (2010). Advanced maternal age and adverse perinatal outcomes in an Asian population. Eur. J. Obstet. Gynecol. Reprod. Biol. 148, 21-26. doi:10.1016/J.EJOGRB.2009.08.022
32. Jacobsson, B., Ladfors, L., and Milsom, I. (2004). Advanced maternal age and adverse perinatal outcome. Obstet. Gynecol. 104, 727-733. doi:10.1097/01.AOG.0000140682.63746.BE
33. Jones, H. N., Woollett, L. A., Barbour, N., Prasad, P. D., Powell, T. L., and Jansson, T. (2009). High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/Bl6 mice. FASEB J. 23, 271-278. doi:10.1096/FJ.08-116889
34. Jungheim, E. S. (2010). Current knowledge of obesity's effects in the pre-and peri-conceptional periods and avenues for future research. Am. J. Obstet. Gynecol. 203, 525-530. doi:10.1016/J.AJOG.2010. 06.043
35. Jungheim, E. S., and Moley, K. H. (2008). The impact of Type 1 and Type 2 diabetes mellitus on the oocyte and the preimplantation embryo. Semin. Reprod. Med. 26, 186-195. doi:10.1055/S-2008-1042957
36. Jungheim, E. S., Schoeller, E. L., Marquard, K. L., Louden, E. D., Schaffer, J. E., and Moley, K. H. (2010). Diet-induced obesity model: abnormal oocytes and persistent growth abnormalities in the offspring. Endocrinology 151, 4039-4046. doi:10.1210/EN.2010-0098
37. Kaneto, H., Xu, G., Song, K.-H., Suzuma, K., Bonner-Weir, S., Sharma, A., and Weir, G. C. (2001). Activation of the hexosamine pathway leads to deterioration of pancreatic b-cell function through the induction of oxidative stress. J. Biol. Chem. 276, 31099-31 104. doi:10.1074/JBC. M104115200
38. Kimura, K., Iwata, H., and Thompson, J. G. (2008). The effect of glucos-amine concentration on the development and sex ratio of bovine embryos. Anim. Reprod. Sci. 103, 228-238. doi:10.1016/J.ANIRE PROSCI.2006.12.014
39. Kitzmiller, J. L., Block, J. M., Brown, F.M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., Jovanovic, L. B., Kjos, S. I., Knopp, R. H., Montoro, M. N., Ogata, E. S., Paramsothy, P., Reader, D. M., Rosenn, B. M., Thomas, A. M., and Kirkman, M. S. (2008). Managing pre-existing diabetes for pregnancy: summary of evidence and consensus recommendation for care. Diabetes Care 31, 1060-1079. doi:10.2337/DC08-9020
40. Le Floch, J. P., Escuyer, P., Baudin, E., Baudin, D., and Perlemuter, L. (1990). Blood glucose area under the curve. Methodological aspects. Diabetes Care 13, 172-175. doi:10.2337/DIACARE.13.2.172
41. Love, D. C., and Hanover, J. A. (2005). The hexosamine signalling pathway: deciphering the "O-GlcNAc code". Sci. STKE 2005, re13. doi:10.1126/STKE.3122005RE13
42. Marshall, S., Bacote, V., and Traxinger, R. R. (1991). Discovery of a metabolic pathway mediating glucose-induced desensitisation of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266, 4706-4712.
43. Martin, J. A., Hamilton, B. E., Sutton, P.D., Ventura, S.J., Menacker, F., and Munson, M. L. (2006). 'Births: Final data for 2004. National Vital Statistics Reports, Vol. 55, No. 1'. (National Center for Health Statistics: Hyattsville, MD, USA.)
44. McCance, D. R. (2011). Pregnancy and diabetes. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 945-958.
45. McClain, D. A. (2002). Hexosamines as mediators of nutrient sensing and regulation in diabetes. J. Diabetes Complications 16, 72-80. doi:10.1016/S1056-8727(01)00188-X
46. McClain, D. A., and Crook, E. D. (1996). Hexosamines and insulin resistance. Diabetes 45, 1003-1009. doi:10.2337/DIABETES.45. 8.1003
47. Metzger, B.E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D.B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., Pettitt, D. J., Sacks, D. A., and Zoupas, C. (2007). Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30(Suppl 2), S251-S260. doi:10.2337/DC07-S225
48. Miletic, T., Aberle, N., Mikulandra, F., Karelovic, D., Zakani, Z., Banovic, I., Tadin, I., Perisa, M., Ognjenovic, M., and Tadic, C. (2002). Perinatal outcome of pregnancies in women aged 40 and over. Coll. Antropol. 26, 251-258.
49. Miller, E., Hare, J. W., Cloherty, J. P., Dunn, P. J., Gleason, R. E., Soeldner, J. S., and Kitzmiller, J. L. (1981). Elevated maternal haemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N. Engl. J. Med. 304, 1331-1334. doi:10.1056/NEJM198105283042204
50. Minge, C. E., Bennett, B. D., Norman, R. J., and Robker, R. L. (2008). Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality. Endocrinology 149, 2646-2656. doi:10.1210/EN.2007-1570
51. Moley, K. H., Vaughn, W. K., DeCherney, A. H., and Diamond, M. P. (1991). Effect of diabetes mellitus on mouse preimplantation embryo development. J. Reprod. Fertil. 93, 325-332. doi:10.1530/JRF.0. 0930325
52. Nybo Andersen, A. M., Wohlfahrt, J., Christens, P., Olsen, J., and Melbye, M. (2000). Maternal age and fetal loss: population-based register linkage study. BMJ 320, 1708-1712. doi:10.1136/BMJ.320.7251.1708
53. Pantaleon, M., Tan, H. Y., Kafer, G.R., and Kaye, P. L. (2010). Toxic effects of hyperglycaemia are mediated by the hexosamine signalling pathway and O-linked glycosylation in early mouse embryos. Biol. Reprod. 82, 751-758. doi:10.1095/BIOLREPROD.109.076661
54. Parnell, S. E., Dehart, D. B., Wills, T. A., Chen, S., Hodge, C. W., Besheer, J., Waage-Baudet, H. G., Charness, M. E., and Sulik, K. K. (2006). Maternal oral intake mouse model for fetal alcohol spectrum disorders: ocular defects as a measure of effect. Alcohol. Clin. Exp. Res. 30, 1791-1798. doi:10.1111/J.1530-0277.2006.00212.X
55. Patti, M. E., Virkamaki, A., Landaker, E. J., Kahn, C.R., and Yki-Jarvinen, H. (1999). Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signalling events in skeletal muscle. Diabetes 48, 1562-1571. doi:10.2337/DIABETES.48. 8.1562
56. Persiani, S., Roda, E., Rovati, L. C., Locatelli, M., Giacovelli, G., and Roda, A. (2005). Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteo-arthritis Cartilage 13, 1041-1049. doi:10.1016/J.JOCA.2005.07.009
57. Ramin, N., Thieme, R., Fischer, S., Schindler, M., Schmidt, T., Fischer, B., and Navarrete Santos, A. (2010). Maternal diabetes impairs gastrulation and insulin and IGF-I receptor expression in rabbit blastocysts. Endocrinology 151, 4158-4167. doi:10.1210/EN.2010-0187
58. Ray, J. G., O'Brien, T. E., and Chan, W. S. (2001). Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q. J. Med. 94, 435-444. doi:10.1093/QJMED/94.8.435
59. Robinson, K. A., Weinstein, M. L., Lindenmayer, G. E., and Buse, M. G. (1995). Effects of diabetes and hyperglycaemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 44, 1438-1446. doi:10.2337/DIABETES. 44.12.1438
60. Rossetti, L., Hawkins, M., Chen, W., Gindi, J., and Barzilai, N. (1995). In vivo glucosamine infusion induces insulin resistance in normogly-caemic but not hyperglycaemic conscious rats. J. Clin. Invest. 96, 132-140. doi:10.1172/JCI118013
61. Salbaum, J. M., and Kappen, C. (2011). Diabetic embryopathy: a role for the epigenome? Birth Defects Res. A Clin. Mol. Teratol. 91, 770-780. doi:10.1002/BDRA.20807
62. Schelbach, C. J., Kind, K. L., Lane, M., and Thompson, J. G. (2010). Mechanisms contributing to the reduced developmental competence of glucosamine-exposed mouse oocytes. Reprod. Fertil. Dev. 22, 771-779. doi:10.1071/RD09193
63. Setnikar, I., Palumbo, R., Canali, S., and Zanolo, G. (1993). Pharmacoki-netics of glucosamine in man. Arzneimittelforschung 43, 1109-1113.
64. Shand, A. W., Bell, J. C., McElduff, A., Morris, J., and Roberts, C. L.(2008). Outcomes of pregnancies in women with pre-gestational diabetes mellitus and gestational diabetes mellitus; a population-based study in New South Wales, Australia, 1998-2002. Diabet. Med. 25, 708-715. doi:10.1111/J.1464-5491.2008.02431.X
65. Simmons, D. (2011). Diabetes and obesity in pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 25-36. doi:10.1016/J.BPOBGYN.2010. 10.006
66. Simon, R. R., Marks, V., Leeds, A. R., and Anderson, J. W. (2011). A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals. Diabetes Metab. Res. Rev. 27, 14-27. doi:10.1002/DMRR.1150
67. Sivojelezova, A., Koren, G., and Einarson, A. (2007). Glucosamine use in pregnancy: an evaluation of pregnancy outcome. J. Womens Health (Larchmt) 16, 345-348. doi:10.1089/JWH.2006.0149
68. Spampinato, D., Giaccari, A., Trischitta, V., Costanzo, B.V., Morviducci, L., Buongiorno, A., Di Mario, U., Vigneri, R., and Frittitta, L. (2003). Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation. Metabolism 52, 1092-1095. doi:10.1016/S0026-0495(03)00182-3
69. Stothard, K. J., Tennant, P. W., Bell, R., and Rankin, J. (2009). Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 301, 636-650. doi:10.1001/JAMA.2009. 113
70. Sulik, K. K., Johnston, M. C., and Webb, M. A. (1981). Fetal alcohol syndrome: embryogenesis in a mouse model. Science 214, 936-938. doi:10.1126/SCIENCE.6795717
71. Sutton-McDowall, M. L., Gilchrist, R. B., and Thompson, J. G. (2004). Cumulus expansion and glucose utilisation by bovine cumulus-oocyte complexes during in vitro maturation: the influence of glucosamine and follicle-stimulating hormone. Reproduction 128, 313-319. doi:10.1530/REP.1.00225
72. Sutton-McDowall, M. L., Mitchell, M., Cetica, P., Dalvit, G., Pantaleon, M., Lane, M., Gilchrist, R. B., and Thompson, J. G. (2006). Glucosamine supplementation during in vitro maturation inhibits subsequent embryo development: possible role of the hexosamine pathway as a regulator of developmental competence. Biol. Reprod. 74, 881-888. doi:10.1095/BIOLREPROD.105. 048553
73. Temple, R. C., Aldridge, V. J., and Murphy, H. R. (2006). Prepregnancy care and pregnancy outcomes in women with Type 1 diabetes. Diabetes Care 29, 1744-1749. doi:10.2337/DC05-2265
74. Teo, C.F., Wollaston-Hayden, E.E., and Wells, L.(2010). Hexosamine flux, the O-GlcNAc modification and the development of insulin resistance in adipocytes. Mol. Cell. Endocrinol. 318, 44-53. doi:10.1016/J.MCE. 2009.09.022
75. Torres, C. R., and Hart, G. W. (1984). Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259, 3308-3317.
76. Vaughan, O. R., Sferruzzi-Perri, A. N., Coan, P. M., and Fowden, A. L. (2012). Environmental regulation of placental phenotype. Reprod. Fertil. Dev. 24, 80-96. doi:10.1071/RD11909
77. Veerababu, G., Tang, J., Hoffman, R. T., Daniels, M. C., Hebert, L. F., Jr, Crook, E. D., Cooksey, R. C., and McClain, D. A. (2000). Overexpres-sion of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity and impaired glucose tolerance. Diabetes 49, 2070-2078. doi:10.2337/DIABETES.49.12.2070
78. Virkamaki, A., Daniels, M. C., Hamalainen, S., Utriainen, T., McClain, D., and Yki-Jarvinen, H. (1997). Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin-sensitive tissues. Endocrinology 138, 2501-2507. doi:10.1210/EN.138.6.2501
79. Vosseller, K., Wells, L., Lane, M. D., and Hart, G. W. (2002). Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipo-cytes. Proc. Natl. Acad. Sci. USA 99, 5313-5318. doi:10.1073/PNAS. 072072399
80. Waller, D.K., Shaw, G.M., Rasmussen, S.A., Hobbs, C.A., Canfield, M.A., Siega-Riz, A. M., Gallaway, M. S., and Correa, A. (2007). Prepregnancy obesity as a risk factor for structural birth defects. Arch. Pediatr. Adolesc. Med. 161, 745-750. doi:10.1001/ARCHPEDI.161.8.745
81. Wang, Q., and Moley, K. H. (2010). Maternal diabetes and oocyte quality. Mitochondrion 10, 403-410. doi:10.1016/J.MITO.2010.03.002
82. Wang, Q., Ratchford, A. M., Chi, M. M.-Y., Schoeller, E., Frolova, A., Schedl, T., and Moley, K. H. (2009). Maternal diabetes causes mito-chondrial dysfunction and meiotic defects in murine oocytes. Mol. Endocrinol. 23, 1603-1612. doi:10.1210/ME.2009-0033
83. Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L., and Brown, M. (2011). Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378, 815-825. doi:10.1016/S0140-6736 (11)60814-3
84. Wyman, A., Pinto, A. B., Sheridan, R., and Moley, K. H. (2008). One-cell zygote transfer from diabetic to non-diabetic mouse results in congenital malformations and growth retardation in offspring. Endocrinology 149, 466-469. doi:10.1210/EN.2007-1273